Stocksigma LogoStocksigma Logo

Hamps Bio Reports Turnaround Performance in H1 FY27 Financial Results

Hamps Bio Limited reported standalone revenue from operations of ₹593.89 lakhs for the half year ended 30th Sep'26, up 48.79% YoY from ₹399.15 lakhs in

Hamps Bio Reports Turnaround Performance in H1 FY27 Financial Results

Hamps Bio Ltd · Outcome · 07 Nov 2026, 1:33 am

Hamps Bio Reports Turnaround Performance in H1 FY27 Financial Results Hamps Bio Limited reported standalone revenue from operations of ₹593.89 lakhs for the half year ended 30th Sep'26, up 48.79% YoY from ₹399.15 lakhs in 30th Sep'25. Standalone net profit turned around to ₹19.76 lakhs from a loss of ₹19.55 lakhs YoY. Consolidated revenue reached ₹730.76 lakhs with a net profit of ₹20.44 lakhs and EPS of ₹0.23. The freeze-dried products division contributed ₹552.86 lakhs to consolidated segment revenue, while pharma products generated ₹216.22 lakhs. All IPO proceeds of ₹622.20 lakhs stand fully utilized.

Original exchange filing (PDF)

More announcements from Hamps Bio Ltd

All Hamps Bio Ltd announcements